Table 3.

Multivariate Progression-Free Survival Analysis. Summarizes the results of a Cox regression model of progression-free survival (PFS) fitted to the covariate data of the study patients.

Covariate	AHR	95% CI	P*
Age(years)†	1.01	1.00-1.02	P=0.287
BMI (kg/m2) ‡	0.99	0.94-1.05	P=0.824
Race/Ethnicity
White	1.00	referent	P=0.321
Black	0.84	0.48-1.49
other	0.61	0.31-1.21
Performance Status
0	1.00	referent	P=0.340
1	1.08	0.79-1.48
2	1.46	0.88-2.42
Grade (differentiation)
Good	1.00	referent	P= 0.146
Moderate	1.61	1.08-2.41
Poor	1.48	0.99-2.19
Not graded	1.57	0.48-5.14
Histology
Serous adenocarcinoma	1.00	referent	P=0.014
Endometriod adenocarcinoma	0.70	0.47-1.05
Mixed	1.05	0.69 -1.60
Clear-cell carcinoma	2.38	1.31- 4.35
Other	1.01	0.64- 1.58
Gross residual disease
No	1.00	referent	P 0.001
Yes	1.51	1.17-1.94
TSIC (days) §	0.97	0.94-1.00	P= 0.049

^*The p-values are from the overall test of significance of each covariate in the model.

^†The AHR denotes the change in risk of progression or death associated with an increase of 1 year of age.

^‡The AHR denotes the change in risk of progression or death associated with a 10% increase in BMI (kg/m²).

^§The AHR denotes the change in risk of progression or death associated with a 10% increase in TSIC (days).